Parker Hannifin (PH)

NYSEIndustrialsIndustrial - MachinerySnapshot 2026-11-04

$910.19-3.68%

Close 2026-11-04 · 1-day change

Investment OutlookAs of Nov 4, 2026

What could strengthen or challenge Parker Hannifin’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+2.3%

+10% or more+5%0%−5%−10% or less

39.01 → 39.92 EPS · FY ending Jun 30, 2028 · 9 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 10 to 9; this is not the number of analysts revising. The ±10% axis is a display range.

Price, analyst earnings & P/E reference

The EPS and P/E reference is not available for PH yet.

Measure / period	Management expectations	Analyst expectations

Management figures unavailable.

Current consensus figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Achieve mid-teens adjusted EPS growth	Parker Hannifin grows sales about 11% yearly and EPS by mid-teens.	Intact	EPS growth falls below mid-teens in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Improve operating margin to about 23.9%	A supporting condition in Parker Hannifin's published investment case. The stated target is >=23.9% operating margin.	Under Pressure	Operating margin falls below 23.4% in FY26	Operating margin: 25.61% FY2026-Q4; GAAP. Published target: >=23.9% operating margin. Annual target cannot be compared with a quarterly or TTM observation. Sep 18, 202625.612511 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Maintain revenue growth near 7% or higher	A primary condition in Parker Hannifin's published investment case. The stated target is >=7% YoY revenue growth.	Intact	YoY revenue growth falls below 7% in FY26	Revenue growth: 9.76% FY2026-Q4; GAAP. Published target: >=7% YoY revenue growth. Annual target cannot be compared with a quarterly or TTM observation. Aug 21, 20269.763852 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-06-30 · fmp

FY2028 EPS$39.92

$37.61 → $39.92 · observed estimates

FY2028 revenue$26.80B

$24.41B → $26.80B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$37.61	$24,406,246,712	6 / 12
2026-07-25	$37.61	$24,406,246,712	6 / 12
2026-07-26	$37.59	$24,391,921,712	6 / 12
2026-07-27	$37.59	$24,391,921,712	6 / 12
2026-07-28	$37.59	$24,391,921,712	6 / 12
2026-07-29	$37.59	$24,391,921,712	5 / 11
2026-07-30	$37.59	$24,391,921,712	5 / 11
2026-07-31	$37.59	$24,391,921,712	5 / 11
2026-08-01	$37.59	$24,391,921,712	5 / 11
2026-08-02	$37.59	$24,391,921,712	5 / 11
2026-08-03	$37.59	$24,391,921,712	5 / 11
2026-08-04	$37.59	$24,391,921,712	6 / 12
2026-08-05	$37.59	$24,391,921,712	6 / 12
2026-08-06	$37.59	$24,391,921,712	6 / 12
2026-08-07	$37.32	$24,209,338,379	6 / 12
2026-08-08	$37.85	$24,270,302,780	15 / 15
2026-08-09	$37.85	$24,270,302,780	15 / 15
2026-08-10	$37.32	$24,209,338,379	6 / 12
2026-08-12	$38.27	$24,412,807,470	21 / 19
2026-08-13	$37.32	$24,209,338,379	6 / 12
2026-08-14	$37.32	$24,209,338,379	6 / 12
2026-08-15	$37.32	$24,209,338,379	6 / 12
2026-08-16	$37.32	$24,209,338,379	13 / 15
2026-08-17	$37.32	$24,209,338,379	13 / 15
2026-08-18	$37.32	$24,209,338,379	5 / 8
2026-08-19	$37.32	$24,209,338,379	5 / 8
2026-08-20	$38.67	$24,381,483,843	5 / 6
2026-08-21	$38.67	$24,381,483,843	6 / 6
2026-08-22	$38.67	$24,381,483,843	6 / 7
2026-08-23	$38.68	$24,381,483,843	6 / 7
2026-08-24	$38.68	$24,381,483,843	7 / 7
2026-08-25	$38.68	$24,381,483,843	7 / 7
2026-08-26	$38.67	$24,381,483,843	7 / 7
2026-08-27	$38.67	$24,381,483,843	7 / 7
2026-08-28	$38.67	$24,381,483,843	7 / 7
2026-08-29	$38.68	$24,381,483,843	6 / 6
2026-08-30	$38.68	$24,381,483,843	6 / 6
2026-08-31	$38.68	$24,381,483,843	6 / 6
2026-09-01	$38.57	$24,381,483,843	6 / 6
2026-09-02	$38.57	$24,381,483,843	6 / 6
2026-09-03	$38.57	$24,381,483,843	6 / 6
2026-09-04	$38.57	$24,381,517,672	6 / 6
2026-09-05	$38.67	$24,433,180,517	6 / 6
2026-09-06	$38.67	$24,433,180,517	7 / 7
2026-09-07	$38.67	$24,433,180,517	7 / 7
2026-09-08	$38.67	$24,433,180,517	7 / 7
2026-09-09	$38.67	$24,433,180,517	7 / 7
2026-09-10	$38.67	$24,433,180,517	7 / 7
2026-09-11	$38.67	$24,433,180,517	7 / 7
2026-09-12	$38.67	$24,433,180,517	7 / 7
2026-09-13	$38.67	$24,433,180,517	7 / 7
2026-09-14	$38.67	$24,433,180,517	7 / 7
2026-09-15	$38.69	$24,433,180,517	7 / 7
2026-09-16	$38.69	$24,433,180,517	7 / 7
2026-09-17	$38.69	$24,433,180,517	7 / 7
2026-09-18	$38.69	$24,433,180,517	7 / 7
2026-09-19	$38.69	$24,433,180,517	7 / 7
2026-09-20	$38.77	$24,418,320,560	7 / 8
2026-09-21	$38.77	$24,418,320,560	7 / 8
2026-09-22	$38.77	$24,418,320,560	7 / 8
2026-09-23	$38.77	$24,418,320,560	7 / 8
2026-09-24	$38.77	$24,418,320,560	7 / 8
2026-09-25	$38.77	$24,418,320,560	7 / 8
2026-09-26	$38.82	$24,418,320,560	7 / 8
2026-09-27	$38.82	$24,418,320,560	8 / 8
2026-09-28	$38.82	$24,418,320,560	8 / 8
2026-09-29	$38.82	$24,418,320,560	8 / 8
2026-09-30	$38.96	$24,617,879,589	8 / 8
2026-10-01	$39.04	$26,797,345,136	9 / 10
2026-10-02	$39.04	$26,797,345,136	9 / 10
2026-10-03	$39.01	$26,797,321,752	9 / 11
2026-10-04	$39.01	$26,797,321,752	9 / 11
2026-10-05	$39.01	$26,797,321,752	10 / 11
2026-10-06	$39.01	$26,797,321,752	10 / 11
2026-10-07	$39.06	$26,747,143,156	10 / 12
2026-10-08	$39.19	$26,738,389,068	11 / 13
2026-10-09	$39.19	$26,738,389,068	10 / 13
2026-10-10	$39.19	$26,738,389,068	10 / 13
2026-10-11	$39.33	$26,768,696,463	10 / 12
2026-10-12	$39.33	$26,768,696,463	10 / 11
2026-10-13	$39.38	$26,768,696,463	10 / 11
2026-10-14	$39.38	$26,759,307,773	11 / 12
2026-10-15	$39.42	$26,814,054,375	10 / 13
2026-10-16	$39.77	$26,814,054,728	10 / 12
2026-10-17	$39.77	$26,814,054,728	10 / 12
2026-10-18	$39.87	$26,814,223,738	11 / 12
2026-10-19	$39.87	$26,814,223,738	11 / 12
2026-10-20	$39.85	$26,803,711,974	11 / 12
2026-10-21	$39.85	$26,803,711,974	11 / 12
2026-10-22	$39.85	$26,803,711,621	11 / 12
2026-10-23	$39.85	$26,803,711,621	11 / 12
2026-10-24	$39.85	$26,803,711,621	11 / 12
2026-10-25	$39.85	$26,803,711,621	11 / 12
2026-10-26	$39.85	$26,803,711,621	11 / 12
2026-10-27	$39.85	$26,803,711,621	11 / 12
2026-10-28	$39.85	$26,803,711,621	11 / 12
2026-10-29	$39.85	$26,803,711,621	11 / 12
2026-10-30	$39.92	$26,803,711,621	11 / 12
2026-10-31	$39.92	$26,803,711,621	11 / 12
2026-11-01	$39.92	$26,803,711,621	10 / 11
2026-11-02	$39.92	$26,803,711,621	10 / 11
2026-11-03	$39.92	$26,803,711,621	9 / 11
2026-11-04	$39.92	$26,803,711,621	9 / 11

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-06-01	21	5	2
2026-07-01	19	5	1
2026-08-01	19	5	1
2026-09-01	19	6	1
2026-10-01	19	6	2
2026-11-01	19	6	2

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 19 Buy / Strong Buy · 6 Hold · 2 Sell / Strong Sell

0 upgrades0 downgrades3 maintains

Recent actions · Oct 6–Nov 4 · 3 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Stifel NicolausOct 19 · prior Aug 7

$1075.00 → $1002.00-6.8%

Mizuho SecuritiesOct 15 · prior May 1

$1050.00 → $1200.00+14.3%

UBSOct 14 · prior Aug 7

$1250.00 → $950.00-24.0%

$0$687.50$1375.00

1 raises · 2 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Achieve mid-teens adjusted EPS growthDirect metric needs a verified mapping
Improve operating margin to about 23.9%Published status: Under Pressure
Maintain revenue growth near 7% or higherRevenue growth: 9.76%

Next proof point

Nov 5, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.1%Typical daily move · historical

Downside history

-19.5%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Parker Hannifin outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 31, 2026

What kind of bet this is

This is a quality industrial growth business with a multi-year view built on sales growth, higher margins, and adjusted earnings growth. The thesis is intact, with management priorities on track, though confidence in the evidence is medium.

What's priced into Parker Hannifin

PH is expensive versus peers, with a 1.15 premium, and expectations appear closely aligned with the evidence. Valuation rose recently, while the priced-in assessment labels expectations justified and fragility low, so the main concern is limited room for weaker execution rather than clearly excessive expectations.

What the fundamentals likely do

Recent results show progress: revenue and adjusted earnings grew, organic sales growth was positive, and margins improved. Fiscal 2027 guidance calls for continued sales growth and a higher adjusted margin, while the longer-term margin goal is 30% by 2031. Near-term risk is rated moderate; a guidance cut would be a meaningful negative, and recent peer misses add caution.

What Parker Hannifin hinges on

Over the next few quarters, the thesis depends on PH sustaining sales, earnings, and margin progress without cutting guidance. Industrial sector conditions are another swing factor: continued strength at GEV, EMR, and TT could support the backdrop, while misses or lower guidance could weaken it. The evidence gives little detail on other forward scenarios.